Nervive, Inc. Company
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.
Founded Date:
2013-12-31
Total Funding:
$3.6M
Employee Number:
1-10
Technology:
NeuroTech
Last Funding Type:
Grant
Investors Number:
3
Industry:
Health Care, Medical, Wellness
Headquarters:
Akron, Ohio, United States
Estimated Revenue:
Less than $1M